These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 314442)

  • 1. The influence of clavulanic acid on the susceptibility to amoxycillin of beta-lactamase producing strains of H. influenzae using different inoculum sizes.
    Van Klingeren B; Dessens-Kroon M
    J Antimicrob Chemother; 1979 May; 5(3):322-3. PubMed ID: 314442
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of the in vitro activity of amoxycillin + clavulanic acid and ampicillin + sulbactam combinations against 50 Haemophilus influenzae strains producing beta lactamase].
    Moittie D; Simonet M; Veron M
    Pathol Biol (Paris); 1989 May; 37(5):390-3. PubMed ID: 2789362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro activity of amoxycillin/clavulanic acid and five other oral antibiotics against clinical isolates of Haemophilus influenzae and Branhamella catarrhalis.
    Fernández-Roblas R; Jiménez Arriero M; Rodriguez-Tudela JL; Soriano F
    J Antimicrob Chemother; 1988 Dec; 22(6):867-72. PubMed ID: 3149634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of low concentrations of clavulanic acid on the in-vitro activity of amoxycillin against beta-lactamase-producing Branhamella catarrhalis and Haemophilus influenzae.
    Cooper CE; Slocombe B; White AR
    J Antimicrob Chemother; 1990 Sep; 26(3):371-80. PubMed ID: 2121699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergy of clavulanic acid, sulbactam and tazobactam (YTR 830) with amoxycillin against fifty beta-lactamase-producing strains of Haemophilus influenzae.
    Simonet M; Moittie D; Philippon A; Descamps P; Veron M
    J Antimicrob Chemother; 1989 May; 23(5):798-800. PubMed ID: 2547748
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative activity of oral beta-lactam antibiotics against fifty strains of Haemophilus influenzae producing a beta-lactamase according to bacterial inoculum].
    Gaillot O; Simonet M
    Pathol Biol (Paris); 1994 May; 42(5):375-7. PubMed ID: 7824299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic antibacterial activity of clavulanic acid and amoxicillin against beta-lactamase-producing strains of Haemophilus ducreyi.
    Girouard YC; Maclean IW; Ronald AR; Albritton WL
    Antimicrob Agents Chemother; 1981 Jul; 20(1):144-5. PubMed ID: 6974538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a true post-beta-lactamase-inhibitor effect of clavulanic acid against Klebsiella pneumoniae and Haemophilus influenzae.
    Murbach V; Dhoyen N; Linger L; Monteil H; Jehl F
    Clin Microbiol Infect; 2001 Dec; 7(12):661-5. PubMed ID: 11843906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic interaction of amoxycillin and clavulanic acid against 132 beta-lactamase positive Haemophilus isolates: a comparison with some other oral agents.
    Lapointe JR; Lavallée C
    J Antimicrob Chemother; 1987 Jan; 19(1):49-58. PubMed ID: 3494009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of amoxycillin/clavulanic acid (augmentin) against beta-lactamase-positive S. aureus, H. influenzae and B. catarrhalis in an in vitro kinetic model.
    Cooper CE; Slocombe B; White AR
    J Chemother; 1989 Jul; 1(4 Suppl):350-1. PubMed ID: 16312434
    [No Abstract]   [Full Text] [Related]  

  • 11. Probability of achieving requisite pharmacodynamic exposure for oral beta-lactam regimens against Haemophilus influenzae in children.
    Pichichero ME; Doern GV; Kuti JL; Nicolau DP
    Paediatr Drugs; 2008; 10(6):391-7. PubMed ID: 18998749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of BRL 17421 against Haemophilus influenzae, Neisseria gonorrhoeae, and Branhamella catarrhalis.
    Piot P; Van Dyck E
    Antimicrob Agents Chemother; 1982 Jan; 21(1):166-7. PubMed ID: 6805422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the inoculum effect with Haemophilus influenzae and beta-lactams.
    Balko T; Karlowsky JA; Palatnick LP; Zhanel GG; Hoban DJ
    Diagn Microbiol Infect Dis; 1999 Jan; 33(1):47-58. PubMed ID: 9990476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Measure by turbidimetry and bactericidal effect of the speed of action of clavulanic acid, amoxicillin and their combinations on a Haemophilus influenzae producer of beta-lactamase].
    Yourassowsky E; Van der Linden MP; Lismont MJ; Crokaert F; Glupczynski Y
    Pathol Biol (Paris); 1987 May; 35(5):526-30. PubMed ID: 3302856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio testing accurately reflect activity against beta-lactamase-producing strains of Haemophilus influenzae and Moraxella catarrhalis?
    Pottumarthy S; Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2005 Nov; 53(3):225-31. PubMed ID: 16257168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of different resistance traits on the competitive growth of Haemophilus influenzae in antibiotic-free medium and selection of resistant populations by different {beta}-lactams: an in vitro pharmacodynamic approach.
    González N; Aguilar L; Alou L; Giménez MJ; Sevillano D; Torrico M; Cafini F; Coronel P; Prieto J
    J Antimicrob Chemother; 2009 Jun; 63(6):1215-22. PubMed ID: 19307171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamics of amoxicillin/clavulanic acid against Haemophilus influenzae in an in vitro kinetic model: a comparison of different dosage regimens including a pharmacokinetically enhanced formulation.
    Löwdin E; Cars O; Odenholt I
    Clin Microbiol Infect; 2002 Oct; 8(10):646-53. PubMed ID: 12390283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can the Etest correctly determine the MICs of beta-lactam and cephalosporin antibiotics for beta-lactamase-negative ampicillin-resistant Haemophilus influenzae?
    Billal DS; Hotomi M; Yamanaka N
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3463-4. PubMed ID: 17606681
    [No Abstract]   [Full Text] [Related]  

  • 19. influence of TEM-1 beta-lactamase on the pharmacodynamic activity of simulated total versus free-drug serum concentrations of cefditoren (400 milligrams) versus amoxicillin-clavulanic acid (2,000/125 milligrams) against Haemophilus influenzae strains exhibiting an N526K mutation in the ftsI gene.
    Torrico M; Aguilar L; González N; Giménez MJ; Echeverría O; Cafini F; Sevillano D; Alou L; Coronel P; Prieto J
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3699-706. PubMed ID: 17664320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media.
    Fenoll A; Aguilar L; Robledo O; Giménez MJ; Tarragó D; Granizo JJ; Gimeno M; Coronel P
    J Antimicrob Chemother; 2007 Aug; 60(2):323-7. PubMed ID: 17562681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.